Cite
HARVARD Citation
Rosenberg, A. et al. (2019). Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up. Oncologist. pp. 1039-e642. [Online].